Terms: = Liver cancer AND RPN1, OST1, 6184, ENSG00000163902, P04843 AND Treatment
3 results:
1. Long-term follow-up of unresectable medium-large hepatocellular carcinoma nodules treated with radiofrequency ablation using a multiple-electrode switching system.
Francica G; Altiero M; Laccetti E; Pezzullo F; Tanga M; Avitabile G; Elameer M; Scaglione M
Br J Radiol; 2019 Jan; 92(1093):20180625. PubMed ID: 30272482
[TBL] [Abstract] [Full Text] [Related]
2. Pentostatin therapy for steroid-refractory acute graft versus host disease: identifying those who may benefit.
Ragon BK; Mehta RS; Gulbis AM; Saliba RM; Chen J; Rondon G; Popat UR; Nieto Y; Oran B; Olson AL; Patel K; Hosing CM; Qazilbash MH; Shah N; Kebriaei P; Shpall EJ; Champlin RE; Alousi AM
Bone Marrow Transplant; 2018 Mar; 53(3):315-325. PubMed ID: 29269797
[TBL] [Abstract] [Full Text] [Related]
3. Clinical outcome of percutaneous RF-ablation of non-operable patients with liver metastasis from breast cancer.
Kümler I; Parner VK; Tuxen MK; Skjoldbye B; Bergenfeldt M; Nelausen KM; Nielsen DL
Radiol Med; 2015 Jun; 120(6):536-41. PubMed ID: 25572543
[TBL] [Abstract] [Full Text] [Related]
